Interaction of α-2-macroglobulin and HSV-1 during infection of neuronal cells

References

• Bishop SA, Hill TJ (1991). Herpes simplex virus in-fection and damage in the central nervous system: immunomodulation with adjuvant, cyclophosphamide and cyclosporin A. Arch Virol 116: 57–68.
   Google Scholar
• Blacker D, Wilcox MA, Laird NM, Rodes L, Horvath SM, Go RCP, Perry R, Watson B Jr, Bassett SS, McInnis MG, Albert MS, Hyman BT, Tanzi RE (1998). a2-Macroglobulin is genetically associated with Alzheimer's disease. Nat Genet 19: 357–360.
   PubMed Web of Science ®Google Scholar
• Borth W (1992). a2-Macroglobulin, a multifunctional bind-ing protein with targeting characteristics. FASEB 1 6: 3345–3353.
   Google Scholar
• Bullido MJ, Artiga MJ, Recuero M, Sastre I, Garcia MA, Aldudo J, Lendon C, Han SW, Morris JC, Frank A, Vazquez J, Goate A, Valdivieso F (1998). A polymor-phism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nat Genet 18: 69–71.
   PubMed Web of Science ®Google Scholar
• Carr DJ, Campbell IL (1999). Transgenic expression of interleukin-6 in the central nervous system confers pro-tection against acute herpes simplex virus type-1 infec-tion. J NeuroVirol 5: 449–457.
   Web of Science ®Google Scholar
• Chesnokova NB, Maichuk YF (1986). Antiproteases in herpetic keratitis. MPS 9: 593–596.
   Google Scholar
• Corder E, Lannfelt L, Mulder M (1998). Apolipoprotein E and herpes simplex virus 1 in Alzheimer's disease. Lancet 352: 1312–1313.
   Google Scholar
• Cribbs DH, Azizeh BY, Cotm an CW, LaFerla FM (2000). Fibril formation and neurotoxicity by a herpes simplex virus glycoprotein B fragment with homology to the Alzheimer's A/3 peptide. Biochemistry 39: 5988–5994. de la Monte S, Lu B-X, Sohn Y-K, Etienne D, Kraft J, Ganju N, Wands JR (2000). Aberrant expression of ni-tric oxide synthase III in Alzheimer's disease: rele-vance to cerebral vasculopathy and neurodegeneration. Neurobiol Aging 21: 309–319.
   Google Scholar
• Dow DJ, Lindsey N, Cairns NJ, Brayne C, Robinson D, Huppert FA, Paykel ES, Xuereb J, Wilcock G, Whittaker JL, Rubinsztein DC (1999). a2-Macroglobulin polymor-phism and Alzheimer's disease risk in the UK. Nat Genet 22: 16–17.
   Google Scholar
• Du Y, Bales KR, Dodel RC, Liu X, Glinn MA, Horn JW, Little SP, Paul SM (1998). a2-Macroglobulin attenu-ates /3-amyloid peptide 1–40 fibril formation and associ-ated neurotoxicity of cultured fetal rat cortical neurons. JNeurochem 70: 1182–1188.
   Google Scholar
• Dunn JT, Spiro R (1967). The a2-macroglobulin of human plasma. J Biol Chem 242: 5549–5555.
   Google Scholar
• Fabrizi C, Businaro R, Lauro GM, Starace G, Fumagalli L (1999). Activated a2-macroglobulin increases /3-amyloid (25–35)-induced toxicity in LAN5 human neuroblastoma cells. Exp Neurol 155: 252–259.
   Google Scholar
• Fujioka N, Akazawa R, Ohashi K, Fujii M, Ikeda M, Kurimoto M (1999). Interleukin-18 protects mice against acute herpes simplex virus type 1 infection. I Virol 73: 2401–2409.
   Google Scholar
• Galvan V, BrandimartiR, Munger J, Roizman B (2000). Bc1-2 blocks a caspase-dependent pathway of apoptosis acti-vated by herpes simplex virus 1 infection in Hep-2 cells. Virol 74: 1931–1938.
   Google Scholar
• Galvan V, Brandimarti R, Roizman B (1999). Herpes sim-plex virus 1 blocks caspase-3-independent and caspase-dependent pathways to cell death. I Virol 73: 3219–3226.
   PubMed Web of Science ®Google Scholar
• Galvan V, Roizman B (1998). Herpes simplex virus 1 induces and blocks apoptosis at multiple steps during infection and protects cells from exogenous inducers in a cell-type-dependent manner. Proc Nat] Acad Sci USA 95: 3931–3936.
   PubMed Web of Science ®Google Scholar
• Ganter U, Strauss S, Jonas U, Weidemann A, Beyreuther K, Volk B, Berger M, Bauer J (1991). a2-Macroglobulin synthesis in interleukin-6-stimulated human neuronal (SH-SY5Y neuroblastoma) cells. FEBS Lett 282: 127–131.
   PubMedGoogle Scholar
• Geraghty RJ, Krummenacher C, Cohen GH, Eisenberg RJ, Spear PG (1998). Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science 280: 1618–1620.
   PubMed Web of Science ®Google Scholar
• Green LC, Wagner DA, Glogowsky J, Skipper PL, Wishnok JS, Tannenbaum JS (1982). Analysis of ni-trate, nitric and (15N) nitrate in biological fluids. Anal Biochem 126: 131–136.
   PubMed Web of Science ®Google Scholar
• Harpel P (1973). Studies on human plasma a2-macroglobulin-enzyme interactions. Evidence for pro-teolytic modification of the subunit chain structure. J Exp Med 138: 508–521.
   Google Scholar
• Immergluck LC, Domowicz MS, Schwartz NB, Herold BC (1998). Viral and cellular requirements for entry of herpes simplex virus type 1 into primary neuronal cells. I Gen Virol 79: 549–559.
   PubMed Web of Science ®Google Scholar
• Itabashi S, Arai H, Matsui T, Higuchi S, Sasaki H (1997). Herpes simplex virus and risk of Alzheimer's disease. Lancet 349: 1102.
   PubMedGoogle Scholar
• Itzhaki R, Lin W-R, Shang D, Wilcock GK, Faragher B, Jamieson GA (1997). Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet 349: 241–244.
   PubMed Web of Science ®Google Scholar
• Itzhaki RF, Lin W-R, Wilcock GK, Faragher B (1998). HSV-1 and risk of Alzheimer's disease. Lancet 352: 238.
   PubMed Web of Science ®Google Scholar
• Ji Z-S, Brecht WJ, Miranda RD, Hussain MM, Innerarity TI, Mahley RW (1993). Role of heparan sulfate proteo-glycansin the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. JBiol Chem 268: 10160–10167.
   PubMed Web of Science ®Google Scholar
• Jones C (1999). Alphaherpervirus latency: its role in dis-ease and survival of the virus in nature. Adv Virus Res 51: 81–133.
   Google Scholar
• Komatsu T, Bi Z, Reiss CS (1996). Interferon-y induced type I nitric oxide synthase activity inhibits viral replication in neurons. J Neuroimmunol 68: 101–108.
   Web of Science ®Google Scholar
• Koyama AH, Miwa Y (1997). Suppression of apopto-sis DNA fragmentation in herpes simplex virus type 1-infected cells. I Virol 71: 2567–2571.
   PubMedGoogle Scholar
• Krimbou L, Tremblay M, Davignon J, Cohn JS (1998). As-sociation of apolipoprotein E with a2-macroglobulin in human plasma. J Lipid Res 39: 2373–2386.
   Google Scholar
• Krfiger R, Menezes-Saecker AMV, Schöls L, Kuhn W, MUller T, Woitalla D, Berg D, Berger K, Przuntek H, Epplen JT, Riess 0 (2000). Genetic analysis of the a2-macroglobulin gene in early-and late-onset Parkinson's disease. Neuroreport 11: 2439–2442.
   Google Scholar
• Laxminarayana R, Devireddy R, Jones CJ (1999). Activation of caspases and p53 by bovine herpesvirus 1 infection results in programmed cell death and efficient virus re-lease. I Virol 73: 3778–3788.
   Google Scholar
• LeBlanc RA, Pesnicak L, Cabral ES, Godleski M, Straus SE (1999). Lack of interleukin-6 (IL-6) enhances susceptibil-ity to infection but does not alter latency or reactivation of herpes simplex virus type 1 in IL-6 knockout mice. Virol 73: 8145–8151.
   Google Scholar
• Leissring MA, Sugarman MC, LaFerla FM (1998). Herpes simplex virus infections and Alzheimer's disease. Drugs Aging 13: 193–198.
   Google Scholar
• Lopez-Guerrero JA, Alonso MA (1997). Nitric oxide pro-duction induced by herpes simplex virus type 1 does not alter the course of the infection in human monocytic cells. I Gen Virol 78: 1977–1980.
   Google Scholar
• L6pez-Guerrero JA, Alonso M, Martin-Belmonte F, Carrasco L (2000). Poliovirus induces apoptosis in the human U937 promonocytic cell line. Virology 272: 250–256.
   Google Scholar
• L6pez-Guerrero JA, Carrasco L (1998). Effect of nitric oxide on poliovirus infection of two human cell lines. I Virol 72: 2538–2540.
   Google Scholar
• Moestrup SK (1994). The a2-macroglobulin receptor and epithelial glycoprotein-330: two giant receptors medi-ating endocytosis of multiple ligands. Biochim Biophys Acta 1197: 197–213.
   Google Scholar
• Pritchett TJ, Paulson JC (1989). Basis for the potent inhibi-tion of influenza virus infection by equine and guinea pig a2-macroglobulin. J Biol Chem 264: 9850–9858.
   PubMed Web of Science ®Google Scholar
• Qiu X, Abdel-Meguid SS (1999). Human herpesvirus proteases. In: Proteases of infectious agents. Academic Press: New York, pp 93–115.
   Google Scholar
• Qiu Z, Strickland DK, Hyman BT, Rebeck GW (1999). a2-Macroglobulin enhances the clearance of endoge-nous soluble 13-amyloid peptide via low-density lipoprotein receptor-related protein in cortical neurons. J Neurochem 73: 1393–1398.
   PubMed Web of Science ®Google Scholar
• Romero F, Martinez-A C, Camonis J, Rebollo A (1999). Aiolos transcription factor controls cell death in T cells by regulating Bc1-2 expression and its cellular localiza-tion. EMBO 11.8: 3419–3430.
   Google Scholar
• Rudrasingham V, Vrieze FW-D, Lambert J-C, Chakraverty S, Kehoe P, Crook R, Amouyel P, Wu W, Rice F, Pérez-Tur J, Frigard B, Morris JC, Carty S, Petersen R, Cottel D, Tunstall N, Holmans P, Lovestone S, Chartier-Harlin M-C, Goate A, Hardy J, Owen MJ, Williams J (1999). a2-Macroglobulin gene and Alzheimer's disease. Nat Genet 22: 17–19.
   Google Scholar
• Sheaffer A, Newcomb WW, Brown JC, Gao M, Weller SK, Tenney DJ (2000). Evidence for controlled incorporation of herpes simplex virus type 1 UL26 protease into cap-sids. I Virol 74: 6838–6848.
   Google Scholar
• Shukla D, Rowe CL, Dong Y, Racaniello VR, Spear PG (1999). The murine homolog (Mph) of human her-pesvirus entry protein B (HveB) mediates entry of pseudorabies virus but not herpes simplex virus type 1 and 2. J Virol 73: 4493–4497.
   PubMed Web of Science ®Google Scholar
• Singleton AB, Gibson AM, McKeith IG, Ballard CA, Perry RH, Ince PG, Edwardson JA, Morris CM (1999). a2-Macroglobulin polymorphisms in Alzheimer's dis-ease and dementia with Lewy bodies. Neuroreport 10: 1507–1510.
   Google Scholar
• Soker S, Svahn CM, Neufeld G (1993). Vascular en-dothelial growth factor is inactivated by binding to a2-macroglobulin and the binding is inhibited by heparin. J Biol Chem 268: 7685–7691.
   PubMed Web of Science ®Google Scholar
• Sottrup-Jensen L (1989). a2-Macroglobulin: structure, shape, and mechanism of proteinase complex forma-tion. J Biol Chem 264: 11539–11543.
   PubMed Web of Science ®Google Scholar
• Strauss S, Bauer J, Ganter U, Jonas U, Berger M, Volk B (1992). Detection of interleukin-6 and a2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab Invest 66: 223–230.
   PubMed Web of Science ®Google Scholar